Mankind Pharma Ltd

Mankind Pharma Ltd

₹ 2,599 -2.68%
23 Jul - close price
About

Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer healthcare products.[1]

Key Points

Leadership[1]
- 1 Rank in Prescriptions over the last 5 yrs.
- Youngest in the Top 5 of the IPM
- 4 By value in the IPM
- 4 Consumer Healthcare brands Market ranked
1 in their categories

  • Market Cap 1,07,268 Cr.
  • Current Price 2,599
  • High / Low 3,055 / 1,901
  • Stock P/E 61.7
  • Book Value 347
  • Dividend Yield 0.00 %
  • ROCE 16.0 %
  • ROE 14.7 %
  • Face Value 1.00

Pros

Cons

  • Stock is trading at 7.48 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Debtor days have increased from 33.4 to 46.0 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
1,726 2,180 2,426 2,091 2,053 2,579 2,708 2,607 2,422 2,893 3,077 3,199 3,079
1,441 1,724 1,835 1,654 1,636 1,924 2,025 2,000 1,836 2,212 2,226 2,383 2,396
Operating Profit 285 456 591 437 417 655 683 606 586 682 850 816 683
OPM % 16% 21% 24% 21% 20% 25% 25% 23% 24% 24% 28% 26% 22%
39 20 31 40 50 63 63 75 94 105 112 87 249
Interest 13 16 10 13 5 6 9 9 9 11 7 221 191
Depreciation 47 78 79 85 85 87 96 110 100 108 106 187 231
Profit before tax 263 382 533 379 377 624 641 562 572 668 849 495 511
Tax % 27% 22% 21% 22% 22% 21% 20% 18% 17% 19% 22% 22% 17%
193 298 423 296 294 494 511 460 477 543 659 385 425
EPS in Rs 4.75 7.30 10.48 7.09 7.13 12.15 12.51 11.33 11.76 13.39 16.31 9.22 10.20
Raw PDF
Upcoming result date: 31 July 2025

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
3,334 5,865 6,214 7,782 8,749 10,260 12,207
2,748 4,427 4,565 5,791 6,848 7,743 9,182
Operating Profit 586 1,438 1,649 1,991 1,902 2,517 3,026
OPM % 18% 25% 27% 26% 22% 25% 25%
76 122 183 210 141 295 548
Interest 2 23 21 60 46 34 432
Depreciation 39 99 119 167 326 378 621
Profit before tax 621 1,438 1,692 1,975 1,671 2,399 2,521
Tax % 29% 27% 24% 26% 22% 19% 20%
445 1,056 1,293 1,453 1,310 1,942 2,011
EPS in Rs 219.33 25.72 31.59 35.78 32.00 47.75 48.26
Dividend Payout % 0% 0% 24% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 14%
5 Years: 16%
3 Years: 16%
TTM: 19%
Compounded Profit Growth
10 Years: 15%
5 Years: 12%
3 Years: 8%
TTM: -4%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 24%
Return on Equity
10 Years: %
5 Years: 20%
3 Years: 18%
Last Year: 15%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 20 40 40 40 40 40 41
Reserves 2,035 3,445 4,682 6,115 7,395 9,323 14,291
0 131 241 873 170 207 8,511
968 1,449 1,397 2,080 2,080 2,313 4,808
Total Liabilities 3,022 5,065 6,360 9,108 9,686 11,883 27,652
316 1,600 1,664 3,588 4,251 4,545 19,005
CWIP 47 317 372 701 550 282 826
Investments 959 829 1,512 1,109 1,346 2,568 2,042
1,700 2,319 2,811 3,709 3,538 4,488 5,780
Total Assets 3,022 5,065 6,360 9,108 9,686 11,883 27,652

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1,070 1,137 920 1,813 2,152 2,413
-436 -1,222 -1,369 -1,052 -2,081 -12,624
-531 -8 605 -740 5 10,233
Net Cash Flow 103 -92 156 22 77 22

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 22 33 19 18 24 30 46
Inventory Days 166 175 243 265 188 180 219
Days Payable 71 145 137 162 126 90 119
Cash Conversion Cycle 117 63 125 121 86 120 146
Working Capital Days 56 35 43 62 45 59 61
ROCE % 37% 32% 22% 26% 16%

Shareholding Pattern

Numbers in percentages

1 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
76.50% 76.50% 76.50% 74.88% 74.87% 74.87% 72.71% 72.70% 72.67%
4.18% 4.18% 6.74% 9.87% 11.58% 12.37% 13.34% 12.92% 13.07%
4.65% 4.56% 9.78% 11.14% 9.94% 9.91% 11.05% 11.47% 11.50%
14.67% 14.76% 6.97% 4.10% 3.61% 2.86% 2.89% 2.89% 2.75%
No. of Shareholders 1,31,9181,34,7311,27,4491,35,1161,53,4501,63,8541,71,2811,80,5971,79,549

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls